[1] Liu X, Nie W, Xie Q, et al. Endostatin reverses immunosuppression of the tumor microenvironment in lung carcinoma[J].Oncol Lett,2018, 15(2): 1874-1880.
[2] 宿濛,周宝森. IL-6和IL-1β单核苷酸多态性与非吸烟女性肺癌易感性的关系[J].中国肺癌杂志, 2014,17(8): 612-617.
[3] Liu CY, Xie WG, Wu S, et al. A comparative study on inflammatory factors and immune functions of lung cancer and pulmonary ground-glass attenuation[J].Eur Rev Med Pharmacol Sci,2017, 21(18): 4098-4103.
[4] 张莹,王芊芊,屈若祎. MTMR3基因多态性与非吸烟者肺癌易感性[J].中华肿瘤防治杂志, 2017,24(2): 79-83.
[5] Seehus CR, Kadavallore A, Torre B, et al. Alternative activation generates IL-10 producing type 2 innate lymphoid cells[J].Nat Commun,2017, 8(1): 1900.
[6] 阎英骥. Hardy-Weinbery平衡定律的拓广[J].云南财贸大学学报, 2004,20(2): 150-152.
[7] 彭丹,刘东利. 人白细胞抗原G基因多态性与非小细胞肺癌易感性的相关性研究[J].心肺血管病杂志, 2017,36(8): 638-641.
[8] Vahl JM, Friedrich J, Mittler S, et al. Interleukin-10-regulated tumour tolerance in non-small cell lung cancer[J].Br J Cancer,2017, 117(11): 1644-1655.
[9] 何燕超,施劲东,梅周芳. 非小细胞肺癌患者外周血Th17和Treg表达的意义[J].复旦大学学报(医学版),2015,42(3): 362-367.
[10] Pang L, Han S, Jiao Y, et al. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation[J].Int J Oncol,2017, 51(1): 25-38.
2018, Vol. 35 
